Taipei Group Files Suit Over Kobayashi Pharmaceutical’s Tainted Benikoji Pills; Consumer Protection Association Suing Subsidiary, Importer

Kobayashi Pharmaceutical Co.’s supplement product Benikoji CholesteHelp
12:38 JST, October 1, 2024
TAIPEI — A consumer support group in Taiwan has filed a lawsuit seeking 168 million New Taiwan dollars (¥755 million) in compensation on behalf of 55 people who complained of health problems caused by Kobayashi Pharmaceutical Co.’s supplements containing benikoji red rice mold.
According to The China Times, among other media, the Consumer Protection Association in Taiwan is suing several companies, including a Kobayashi’s subsidiary and the product importer, in the Taipei district court on Friday.
"Society" POPULAR ARTICLE
-
Earthquake Hits with Epicenter in Central Tokyo; No Tsunami Warning
-
Princess Aiko Delivers First Address During Official Duty; Daughter of Emperor and Empress Speaks at Opening of International Medical Conference
-
Suspicious Plastic Bottle Containing Black Liquid Found on Tokaido Shinkansen Train; Police Working to Identify Contents
-
Man Arrested on Suspicion of Drunk Driving after Rear-ending Bus in Yokosuka
-
2025 Expo Osaka: Visitor Surge Expected in Latter Half as Increased Ticket Sales Not Leading to More Attendance Yet
JN ACCESS RANKING
-
Core Inflation in Japan’s Capital Sharply Accelerates in April
-
U.S. Holds Fire Over Yen Exchange Rate Targets; Bessent Said to Understand Negative Impact on Markets
-
Japanese Govt Mulls Raising Number of Cars to be Imported Under Simplified Screen System in U.S. Tariff Negotiations
-
Rice Prices Rise for 15th Straight Week, with Releases of Stockpiled Rice Slow to Circulate
-
Japan Must Take Lead in Maintaining Free Trade System, Says Chairman of Japan Trade Group